IL13, interleukin 13, 3596

N. diseases: 587; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003615
Disease: Appendicitis
Appendicitis
0.010 GeneticVariation disease BEFREE Associations with appendicitis were found for SNPs IL-13 rs1800925 with odds ratio (OR) 6.02 (95% CI 1.52-23.78) for T/T versus C/C + T/T, for IL-17 rs2275913 with OR 2.38 (CI 1.24-4.57) for A/A vs G/G + GA, for CCL22 rs223888 with OR 0.12 (0.02-0.90), and for A/A vs G/G + GA. Signs of effect modification of age for the association with appendicitis were found for IL-13 rs1800925 and CTLA4 rs3087243. 31845023 2020
CUI: C0010036
Disease: Corneal dystrophy
Corneal dystrophy
0.010 Biomarker disease BEFREE VCAM, IL-13 and Fractalkine were significantly elevated in epithelial and macular CD. 31756391 2020
CUI: C0003492
Disease: Aortic coarctation
Aortic coarctation
0.010 AlteredExpression disease BEFREE The molecular expression of IL-13 in EAT is directly related to the molecular expression of genes associated with extracellular matrix (ECM) turnover, macrophage infiltration and promotion of the formation of ectopic calcific nodules involved in aorta coarctation and calcification. 31102584 2019
CUI: C0005411
Disease: Biliary Atresia
Biliary Atresia
0.010 AlteredExpression disease BEFREE Expression levels of IL-33, TGF-β1, and IL-13 were significantly increased in BA patients compared to control group, especially in poor-prognosis BA patients. 31632941 2019
CUI: C0006309
Disease: Brucellosis
Brucellosis
0.010 GeneticVariation disease BEFREE IL-13 (-1512A/C) was associated with Brucellosis risk in dominant model (OR (95% CI) = 2.17 (1.02-4.62)), P-value = 0.041. 31818255 2019
CUI: C0007570
Disease: Celiac Disease
Celiac Disease
0.010 Biomarker disease BEFREE This review deals with IL-13 in several experimental colitis models -such as oxazolone-, trinitrobenzene sulfonic acid- or dextran sodium sulphate-induced colitis- and chronic intestinal inflammatory disorders -including celiac disease, UC and Crohn's disease-, and it also highlights the attempts to modulate IL-13 as therapeutic tool. 30844559 2019
CUI: C0007785
Disease: Cerebral Infarction
Cerebral Infarction
0.010 Biomarker disease BEFREE Taken together, delivery of IL-13 enhances microglial/macrophage anti-inflammatory responses in vivo and in vitro, decreases ischemia-induced brain cell death, and improves sensory and motor functions in the pMCAo mouse model of cerebral ischemia. 31372938 2019
CUI: C0008677
Disease: Bronchitis, Chronic
Bronchitis, Chronic
0.010 Biomarker disease BEFREE To develop CB-like-mucosa (PBEC-ALI/CB), 1<b> </b>ng/ml interleukin-13 was added to the basal media of PBEC-ALI culturing. 31462114 2019
CUI: C0009404
Disease: Colorectal Neoplasms
Colorectal Neoplasms
0.010 AlteredExpression group BEFREE The formation of aberrant crypt foci and colorectal tumors were more frequent in obese mice compared with WT mice, and both serum interleukin (IL)-13 and IL-13 receptor (R) expression in the normal intestinal mucosal epithelium were significantly increased in the obese mice. 31099450 2019
CUI: C0011265
Disease: Presenile dementia
Presenile dementia
0.010 AlteredExpression disease BEFREE These results suggest that IL-4 and IL-13 that were endogenously expressed from reactive microglia may play a critical role on neuronal death by regulating oxidative stress during the neurodegenerative diseases, such as Alzheimer's disease and dementia. 31010119 2019
CUI: C0011608
Disease: Dermatitis Herpetiformis
Dermatitis Herpetiformis
0.010 Biomarker disease BEFREE In addition, Th2-type cytokines, such as interleukin (IL)-4, IL-5 and IL-13, may be important in the development of skin lesions in fibrillar-type DH (especially in the infiltration of tissue by eosinophils), as in granular-type DH. 31106757 2019
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.010 AlteredExpression disease BEFREE The proportion of ILC2s and the levels of IL-4, IL-5, and IL-13 were significantly increased in DKD patients and were positively correlated with the severity of DKD (<i>P</i> < 0.05). 31355294 2019
CUI: C0013238
Disease: Dry Eye Syndromes
Dry Eye Syndromes
0.010 Biomarker disease BEFREE Moreover, the concentrations of IL-13 and IL-5 released from activated type 2 helper T (Th2) cells increased in the tears of patients with DE. 31673224 2019
CUI: C0018572
Disease: Hand, Foot and Mouth Disease
Hand, Foot and Mouth Disease
0.010 GeneticVariation disease BEFREE The G allele at the rs20541 locus of IL-13 gene and the A allele at the rs179019 locus of the TLR-7 gene were not risk factors for severe HFMD in either male or female patients. 30807256 2019
CUI: C0018824
Disease: Heart valve disease
Heart valve disease
0.010 AlteredExpression group BEFREE IL-13 gene expression in altered EAT is directly related to the expression of genes involved in ECM turnover and the formation of ectopic calcific nodules, suggesting measurements of EAT as a stratification risk factor for valve instability in the VHD patients. 31102584 2019
CUI: C0019202
Disease: Hepatolenticular Degeneration
Hepatolenticular Degeneration
0.010 Biomarker disease BEFREE In addition, the higher Th1 cells (IL-2, TNF-α, and TNF-β), Th2 cells (IL-13), and Th17 (TGF-β1, IL-23) and the course of WD were associated with the severity of the neurological symptoms for WD patients. 30644005 2019
CUI: C0021831
Disease: Intestinal Diseases
Intestinal Diseases
0.010 Biomarker group BEFREE The role of interleukin-13 in chronic inflammatory intestinal disorders. 30844559 2019
CUI: C0022577
Disease: Keratoconjunctivitis, Vernal
Keratoconjunctivitis, Vernal
0.010 AlteredExpression disease BEFREE Th2 cytokines (IL-4, IL-5 and IL-13) and OX40 in the VKC specimens showed increased expression. 30601284 2019
CUI: C0023470
Disease: Myeloid Leukemia
Myeloid Leukemia
0.010 AlteredExpression disease BEFREE Cytoprotection achieved with IL-4 and IL-13 is mediated by the early activation of signal transducer and activator of transcription 6 (STAT6) in beta cells, leading to the upregulation of anti-apoptotic proteins, including myeloid leukaemia-1 (MCL-1) and B cell lymphoma-extra large (BCLXL). 30338340 2019
CUI: C0023652
Disease: Lichen Sclerosus et Atrophicus
Lichen Sclerosus et Atrophicus
0.010 AlteredExpression disease BEFREE OZOILE and steroid treatment caused an increase in the transcript levels of IL-13 and e-cadherin in the foreskin of patients affected by LS in comparison to untreated foreskin (p < 0.001). 30991399 2019
CUI: C0026269
Disease: Mitral Valve Stenosis
Mitral Valve Stenosis
0.010 Biomarker disease BEFREE T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients. 31237799 2019
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.010 Biomarker disease BEFREE Ethanol Induction of Innate Immune Signals Across BV2 Microglia and SH-SY5Y Neuroblastoma Involves Induction of IL-4 and IL-13. 31510019 2019
CUI: C0036205
Disease: Sarcoidosis, Pulmonary
Sarcoidosis, Pulmonary
0.010 Biomarker disease BEFREE IL-13-regulated gene pathways were confirmed in human sarcoidosis lung and mediastinal lymph node tissues. 30134122 2019
CUI: C0040954
Disease: Infection by Trichuris trichiura
Infection by Trichuris trichiura
0.010 Biomarker disease BEFREE Our results suggest that exploiting the biology of p43 may open up new approaches to modulating IL-13 function and control of Trichuris infections. 31138806 2019
CUI: C0085436
Disease: Meningitis, Cryptococcal
Meningitis, Cryptococcal
0.010 Biomarker disease BEFREE HIV-infected individuals developing cryptococcal meningitis with CD4 ≥100 cells/μL presented more frequently with altered mental status despite having 10-fold lower fungal burden and with greater Th2 (IL-13) immune response. 30325463 2019